| Company Name: | I-Trax Inc. | | Ticker Symbol: | DMX | | | WWW Address: | www.i-trax.com | | CEO: | R. Dixon Thayer | | No. of Employees: | 1,327 | | Common Issue Type: | CS | | Business Description: | The Company provides integrated workplace medical, pharmacy, wellness, fitness, and disease management services to enhance the health and productivity of the employees, dependents, and retirees of its clients.
|
| | | Industry Information: | HEALTH SERVICES - Health Care Plans [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 5.37 |  0.0 | - | - | 0 | 5.39 | 5.37 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 224.5 | 41.8 | 1.86 | -0.01 | 0.00 | 0.0 | 0.0 | 5.40 - 2.31 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 5.37 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 224.2 | mil |
| Latest Shares Outstanding | 41.8 | mil |
| Earnings pS (EPS) | -0.01 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 107,907 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 40.3 | mil |
| Float as % of Shares Outstanding | 96.5 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 20.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 24.3 | % |
| EBITDA Margin | 3.4 | % |
| Pre-Tax Profit Margin | 0.5 | % |
| Assets Turnover | 1.3 | % |
| Return on Assets (ROA) | 0.2 | % |
| Return on Equity (ROE) | 0.3 | % |
| Return on Capital Invested (ROCI) | 0.2 | % |
| Current Ratio | 1.3 | |
| Leverage Ratio (Assets/Equity) | 1.8 | |
| Interest Cover | 2.3 | |
| Total Debt/Equity (Gearing Ratio) | 0.26 | |
| LT Debt/Total Capital | 20.0 | % |
| Working Capital pS | 0.23 | $ |
| Cash pS | 0.24 | $ |
| Book-Value pS | 1.65 | $ |
| Tangible Book-Value pS | -0.17 | $ |
| Cash Flow pS | 0.09 | $ |
| Free Cash Flow pS | -0.17 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.25 | |
| Price/Tangible Book Ratio | -31.59 | |
| Price/Cash Flow | 59.7 | |
| Price/Free Cash Flow | -31.6 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.4 | 99 | 2,257 | 2,223 |
| 4 Weeks | 5.40 | 5.35 | 5.37 | 0.0 | 97 | 3,004 | 57,077 |
| 13 Weeks | 5.40 | 3.24 | 3.34 | 60.8 | 159 | 5,791 | 359,046 |
| 26 Weeks | 5.40 | 2.31 | 3.83 | 40.2 | 150 | 3,411 | 419,605 |
| 52 Weeks | 5.40 | 2.31 | 4.51 | 19.1 | 127 | 2,168 | 542,117 |
| YTD | 5.40 | 2.65 | - | 51.3 | 158 | 4,435 | 372,526 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 5.37 | 5.38 | 4.76 | 3.95 | 3.89 | 1.86 | 1.20 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 126.20 | 78.2 | 21.61 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 13.57 | NA | -28.57 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 14.9 | 19.2 | 14.9 |
| Earnings % | -88.8 | -76.0 | -88.8 |
| EPS % | -100.0 | -100.0 | -100.0 |
| EPS $ | -0.02 | -0.02 | -0.02 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 7.85 |
| Current Ratio | 1.3 |
| Quick Ratio (Acid Test) | 1.3 |
| Liquidity Ratio (Cash) | 0.33 |
| Receivables Turnover | 5.6 |
| Average Collection Period | 64 |
| Working Capital/Equity | 13.8 |
| Working Capital pS | 0.23 |
| Cash-Flow pS | 0.09 |
| Free Cash-Flow pS | -0.17 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.89 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 43.2 |
| Total Debt/Equity (Gearing Ratio) | 0.26 |
| LT Debt/Equity | 0.25 |
| LT Debt/Capital Invested | 25.1 |
| LT Debt/Total Liabilities | 32.6 |
| Interest Cover | 2.3 |
| Interest/Capital Invested | 0.62 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 13.99 |
| Tobin's Q Ratio | 1.84 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 54.60 |
| Enterprise Value (EV)/Free Cash Flow | -51.41 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -31.59 |
| Price/Book Ratio - LTM | 3.25 |
| Price/Cash Flow Ratio | 59.7 |
| Price/Free Cash Flow Ratio - LTM | -31.6 |
| Price/Sales Ratio | 1.57 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 191.5 |
| P/E Ratio (52 weeks ago) - LTM | 451.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.41 |
| Current Liabilities pS | 0.75 |
| Tangible Book Value pS - LTM | -0.17 |
| Book Value pS - LTM | 1.65 |
| Capital Invested pS | 2.06 |
| Cash pS - LTM | 0.24 |
| Cash Flow pS - LTM | 0.09 |
| Free Cash Flow pS - LTM | -0.17 |
| Earnings pS (EPS) | -0.01 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -4.85 |
| Free Cash Flow Margin 5YEAR AVG | -29.42 |
| Net Profit Margin | 0.1 |
| Net Profit Margin - 5YEAR AVRG. | -5.2 |
| Equity Productivity | 2.08 |
| Return on Equity (ROE) | 0.3 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.66 |
| Return on Capital Invested (ROCI) | 0.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -7.5 |
| Assets Productivity | 1.30 |
| Return on Assets (ROA) | 0.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | -5.4 |
| Gross Profit Margin | 24.3 |
| Gross Profit Margin - 5YEAR AVRG. | 24.7 |
| EBITDA Margin - LTM | 3.4 |
| EBIT Margin - LTM | 0.9 |
| Pre-Tax Profit Margin | 0.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -5.2 |
| Effective Tax Rate | 72.4 |
| Effective Tax Rate - 5YEAR AVRG. | 23.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 74 |
| Revenue per Employee | 107,907 |
| Net Income per Employee | 149 |
| Average Collection Period | 74 |
| Receivables Turnover | 5.6 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 7.57 |
| Assets/Revenue | 0.77 |
| Net Working Capital Turnover | 15.00 |
| Fixed Assets Turnover | 1.77 |
| Total Assets Turnover | 1.3 |
| Revenue per $ Cash | 14.21 |
| Revenue per $ Plant | 30.24 |
| Revenue per $ Common Equity | 2.08 |
| Revenue per $ Capital Invested | 1.66 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 20.9 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 22.1 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |